Pharmaceutical Firm Prolius Medicine Submits Listing Application to Hong Kong Exchange

Short Sale List Update Takes Effect Today with 51 Additions Including GenFleet-B

IPO Preview: Can Pugi Pharma, a Leader in Topical Targeted Therapies, Justify Its 2.4 Billion Yuan Valuation?

TYK MEDICINES-B Receives Stock Exchange Approval for H-Share Full Circulation Plan

Healthcare Sector Shows Divergence as Scarce Leaders Gather, HK Stock Connect Medical ETF (159137) Rises for Fourth Consecutive Session at Low Levels! Institutions Hint at Hong Kong's "Spring Festival Rally"

Xilong Scientific Confirms Product Range Includes Pharmaceutical Ingredients and Intermediates

Decoding Investment Clues from Latest Earnings Reports of Pharma Giants

BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Share Circulation

Qinghai Implements Multiple Measures to Promote Traditional Chinese and Tibetan Medicine Innovation

BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Circulation of H Shares

Tasly Pharmaceutical Reports 11.05 Billion Yuan Net Profit for 2025, Marking 15.68% Year-on-Year Growth

TYK MEDICINES-B's New Drug Application for TY-9591 Tablets Accepted by Regulatory Authority

TYK MEDICINES-B Shares Surge Nearly 5% in Afternoon Session as Key Drug Gains Priority Review Status

Great Wall Fund's Healthcare Investment Team Maintains Optimism on Medical Technology and Seeks New Rationale for Innovative Drugs

BOCOM International Forecasts Continued Stable Growth for Healthcare Sector This Year, Recommends Seeking Undervalued Stocks

Healthcare Sector Demonstrates Resilience as Traditional Chinese Medicine Leaders Lead Gains, While Exclusive Pharmaceutical ETF Defies Market Downturn

OpenAI Explores New Revenue Streams in Pharma: Plans "Investment Plus Royalty" Model to Target AI-Driven Biotech Innovation

32 New Funds Launched This Week: 27 Firms Including GF and E Fund Compete Across Battery, AI, Healthcare, and Gold Sectors, Some Products Already Closed Early

Hubei Jumpcan Pharmaceutical (600566.SZ) Subsidiary Signs Exclusive Commercialization Agreement with Puqi Pharmaceutical

283 Healthcare Stocks Preview 2025 Performance: Top Forecast Shows Over 32-Fold Increase, 39 Stocks Including Zhifei Biological Report First Loss